Breast cancer mortality remains a significant health crisis in Southeast Asia, with an estimated 130 women dying daily. The region accounts for 39% of global cases, and mortality rates far exceed those in East Asia and Africa. Projections indicate a rise in incidence and deaths between 2020 and 2030, largely due to late diagnoses and unequal access to quality care. The impact extends beyond health, disrupting family livelihoods as women often serve as primary caregivers and income earners.
Late-stage diagnoses are prevalent across Southeast Asia, exacerbated by factors such as long travel times to clinics, low screening rates, fragmented health records, and limited access to specialists, particularly in rural areas. Addressing these gaps is vital for the social and economic well-being of communities.
Decentralized care models and community-based services are emerging as critical solutions. Roche, in partnership with ministries of health, has launched initiatives like "Cancer Care Closer to Community" in Malaysia. This program brings follow-up treatment closer to patients' homes, reducing travel burdens and improving care continuity. It complements national cancer control programs by ensuring treatment completion within communities.
Community engagement plays a crucial role in raising awareness and reducing stigma. Programs in Vietnam, such as "We Care for Her" and "Joining Hands for Her," utilize survivor advocacy, public education, and peer support networks to encourage early help-seeking.
To combat the growing burden, sustained investment and cross-border collaboration are essential. The Global Breast Cancer Initiative aims to reduce mortality by 2.5% annually, potentially saving millions of lives. Key priorities include improving organized screening programs, enhancing referral and treatment pathways, establishing sustainable funding, and strengthening performance tracking.
Targeted investments in early detection and care are critical for improving patient outcomes. Policy initiatives, such as the Philippines' National Integrated Cancer Control Act, have established cancer assistance funds and expanded insurance coverage for advanced treatments. Singapore's subsidies for genetic testing and expanded insurance coverage for preventive surgeries further enhance accessibility.
Public-private partnerships are vital for expanding access to care. Collaborations between governments, the private sector, and NGOs are driving progress. The "Empower Her" co-funding program in Malaysia, a partnership between Roche and Sarawak Energy, sponsors treatment for low-income women. In Vietnam, partnerships focus on patient assistance programs and advocating for expanded insurance coverage.
Moving forward, sustained funding, strong legislation, and multi-stakeholder engagement are key to improving access, equity, and outcomes for women with breast cancer. The goal is to ensure that every woman in Southeast Asia can access timely, high-quality breast cancer care, regardless of her location or background.